RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC after failure of platinum-based chemotherapy in Brazil

Trial Identifier: D133HR00041
Sponsor: AstraZeneca
Start Date: July 2024
Primary Completion Date: June 2025
Study Completion Date: June 2025
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Brazil, Rio Grande do Norte Natal, Rio Grande do Norte, Brazil, 59062-000
Brazil, Sao Paulo Sao Paulo, Brazil, 05652-900
Brazil, Sao Paulo Sao Paulo, Brazil, 01323-020
Brazil, Sao Paulo Sao Paulo, Brazil, 01308-050
Brazil, Sao Paulo Sao Paulo, Brazil, 01333-010